US2065593A
(en)
|
|
1936-12-29 |
|
Water-soluble diazoimino com |
FR472489A
(fr)
|
1914-02-20 |
1914-12-08 |
Stas Motor Ges M B H |
Bague de garniture métallique pour pistons
|
FR803619A
(fr)
|
1935-03-23 |
1936-10-05 |
Ig Farbenindustrie Ag |
Acide du type dihydroxystilbène-dicarboxylique et son procédé de préparation
|
US2065900A
(en)
|
1935-03-23 |
1936-12-29 |
Gen Aniline Works Inc |
Dihydroxystilbene-dicarboxylic acid and a process of preparing it
|
DE637259C
(de)
|
1935-03-24 |
1936-10-27 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung einer Dioxystilbendicarbonsaeure
|
FR803201A
(fr)
|
1935-07-08 |
1936-09-25 |
Ste Ind Chim Bale |
Préparation d'acides sulfoniques
|
US2071329A
(en)
|
1935-08-22 |
1937-02-23 |
Solvay Process Co |
Method of recovering phthalic anhydride
|
DE652772C
(de)
|
1935-11-07 |
1937-11-08 |
I G Farbenindustrie Akt Ges |
Verfahren zur Herstellung von N-Dihydroazinen der Anthrachinonreihe
|
GB728767A
(en)
|
1951-10-12 |
1955-04-27 |
Wander Ag Dr A |
2-substituted chromone compounds, and a method of making same
|
US3251837A
(en)
|
1962-09-14 |
1966-05-17 |
Pfizer & Co C |
Derivatives of 1, 2, 4-benzothiadiazine-1, 1-dioxides
|
GB1179019A
(en)
|
1967-05-23 |
1970-01-28 |
Produits Chimique Soc Et |
Polynicotinic Esters of Flavonoids
|
FR6928M
(xx)
|
1967-11-24 |
1969-05-05 |
|
|
US3600394A
(en)
|
1968-05-17 |
1971-08-17 |
Searle & Co |
2-aminoalkyl-3-arylisocarbostyrils
|
US3930024A
(en)
|
1969-09-02 |
1975-12-30 |
Parke Davis & Co |
Pharmaceutical compositions and methods
|
US3773946A
(en)
|
1969-09-02 |
1973-11-20 |
Parke Davis & Co |
Triglyceride-lowering compositions and methods
|
FR2244493A1
(en)
|
1973-08-09 |
1975-04-18 |
Pluripharm |
Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis
|
DE2349024A1
(de)
|
1973-09-26 |
1975-04-10 |
Schering Ag |
6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione
|
US5098903A
(en)
*
|
1980-03-07 |
1992-03-24 |
Board Of Regents Of The University Of Oklahoma |
Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents
|
IL64542A0
(en)
|
1981-12-15 |
1982-03-31 |
Yissum Res Dev Co |
Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
JPS60136512A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
脂質代謝改善剤
|
DE3423166A1
(de)
|
1984-06-22 |
1986-01-02 |
Epis S.A., Zug |
Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
EP0182213B1
(en)
|
1984-11-08 |
1990-09-26 |
Sumitomo Pharmaceuticals Company, Limited |
Carbapenem compounds and production thereof
|
DE3515882A1
(de)
|
1985-05-03 |
1986-11-06 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Arzneimittel, enthaltend pyridinone mit antithrombotischen wirkungen und verfahren zu ihrer herstellung
|
DE3601417A1
(de)
|
1986-01-20 |
1987-07-23 |
Nattermann A & Cie |
2'-alkyl-(alkenyl-) substituierte quercetine
|
EP0258190B1
(de)
|
1986-08-29 |
1991-11-27 |
Ciba-Geigy Ag |
Verfahren zur Herstellung von aromatischen Ether- und Thioetherverbindungen
|
ES2053508T3
(es)
|
1986-11-24 |
1994-08-01 |
Fujisawa Pharmaceutical Co |
Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
|
GB8804058D0
(en)
|
1988-02-22 |
1988-03-23 |
Fujisawa Pharmaceutical Co |
3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds
|
US4925838A
(en)
|
1988-03-18 |
1990-05-15 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
US4963544A
(en)
|
1988-05-23 |
1990-10-16 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
GB8926981D0
(en)
|
1988-12-23 |
1990-01-17 |
Ici Plc |
Heterocyclic derivatives
|
WO1991000858A1
(en)
|
1989-07-07 |
1991-01-24 |
Schering Corporation |
Pharmaceutically active compounds
|
IE64358B1
(en)
|
1989-07-18 |
1995-07-26 |
Ici Plc |
Diaryl ether heterocycles
|
GB9018134D0
(en)
|
1989-09-29 |
1990-10-03 |
Ici Plc |
Heterocyclic derivatives
|
EP0735026A1
(en)
|
1990-06-05 |
1996-10-02 |
Toray Industries, Inc. |
Method for the production of isoquinoline derivatives and their use as intermediates in the preparation of indole derivatives
|
JP2999579B2
(ja)
|
1990-07-18 |
2000-01-17 |
武田薬品工業株式会社 |
Dnaおよびその用途
|
GB9025832D0
(en)
|
1990-11-28 |
1991-01-09 |
Ashwell Geoffrey J |
Novel films for nonlinear optical applications
|
IE913866A1
(en)
|
1990-11-28 |
1992-06-03 |
Ici Plc |
Aryl derivatives
|
US5141970A
(en)
*
|
1990-12-10 |
1992-08-25 |
Loctite (Ireland) Limited |
Method of forming high-temperature resistant polymers
|
US5126351A
(en)
|
1991-01-24 |
1992-06-30 |
Glaxo Inc. |
Antitumor compounds
|
MX9200299A
(es)
|
1991-02-07 |
1992-12-01 |
Roussel Uclaf |
Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
|
EP0533902A1
(en)
|
1991-04-10 |
1993-03-31 |
Octamer, Inc. |
A method for inhibition of retroviral replication
|
US5409930A
(en)
|
1991-05-10 |
1995-04-25 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
US5124337A
(en)
|
1991-05-20 |
1992-06-23 |
Schering Corporation |
N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase
|
US5223506A
(en)
|
1991-06-04 |
1993-06-29 |
Glaxo Inc. |
Cyclic antitumor compounds
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
US5250679A
(en)
|
1991-10-18 |
1993-10-05 |
Genentech, Inc. |
Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
|
FR2689127B1
(fr)
|
1992-03-31 |
1994-05-06 |
Adir Cie |
Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
|
DE4215588A1
(de)
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Biphenylmethyl-substituierte Pyridone
|
DE4215587A1
(de)
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone
|
GB9218334D0
(en)
|
1992-08-28 |
1992-10-14 |
Ici Plc |
Heterocyclic compounds
|
AU5850894A
(en)
|
1992-12-23 |
1994-07-19 |
Procept, Inc. |
Novel agents for inhibition of hiv infectivity and use therefor
|
JPH0725761A
(ja)
|
1993-07-09 |
1995-01-27 |
Kureha Chem Ind Co Ltd |
軟骨保護剤
|
EP0709373B1
(en)
|
1993-07-23 |
2001-10-17 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Pyrrolidine derivative
|
US5707547A
(en)
|
1993-08-03 |
1998-01-13 |
Sumitomo Chemical Company, Limited |
Trans-olefin compounds, method for production thereof, liquid crystal composition containing the same as active ingredient, and liquid crystal element using said composition
|
AU680736B2
(en)
|
1994-02-25 |
1997-08-07 |
Banyu Pharmaceutical Co., Ltd. |
Carbapenem derivative
|
EP0749974B1
(en)
|
1994-03-08 |
2001-06-27 |
Otsuka Pharmaceutical Factory, Inc. |
Phosphonic diester derivative
|
FR2718329B1
(fr)
|
1994-03-21 |
2002-09-20 |
Rhone Poulenc Rorer Sa |
Lapin transgénique sensibilisé aux dyslipoprotéinémies.
|
US6048903A
(en)
|
1994-05-03 |
2000-04-11 |
Robert Toppo |
Treatment for blood cholesterol with trans-resveratrol
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
GB2292149A
(en)
|
1994-08-09 |
1996-02-14 |
Ferring Res Ltd |
Peptide inhibitors of pro-interleukin-1beta converting enzyme
|
IL115256A0
(en)
|
1994-11-14 |
1995-12-31 |
Warner Lambert Co |
6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
|
US5446071A
(en)
|
1994-11-18 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
JP4140981B2
(ja)
|
1994-12-26 |
2008-08-27 |
東菱薬品工業株式会社 |
再狭窄症及び動脈硬化症治療薬
|
US5648387A
(en)
|
1995-03-24 |
1997-07-15 |
Warner-Lambert Company |
Carboxyalkylethers, formulations, and treatment of vascular diseases
|
AU5259296A
(en)
|
1995-04-07 |
1996-10-23 |
Warner-Lambert Company |
Flavones and coumarins as agents for the treatment of athero sclerosis
|
EP0747051B1
(en)
|
1995-06-07 |
2002-07-24 |
Eli Lilly And Company |
Treatment of diseases by inducing BEF-1 transcription factor
|
CN1090621C
(zh)
|
1995-08-30 |
2002-09-11 |
株式会社大冢制药厂 |
制备喹唑啉-4-酮衍生物的方法
|
US5783577A
(en)
|
1995-09-15 |
1998-07-21 |
Trega Biosciences, Inc. |
Synthesis of quinazolinone libraries and derivatives thereof
|
AU4858596A
(en)
|
1995-09-15 |
1997-04-01 |
Torrey Pines Institute For Molecular Studies |
Synthesis of quinazolinone libraries
|
AU706262B2
(en)
|
1995-10-23 |
1999-06-10 |
Osteoscreen, Inc. |
Compositions and methods for treating bone deficit conditions
|
RU2135494C1
(ru)
|
1995-12-01 |
1999-08-27 |
Санкио Компани Лимитед |
Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина
|
US5756736A
(en)
|
1996-01-26 |
1998-05-26 |
Syntex (U.S.A.) Inc. |
Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
|
US5763608A
(en)
|
1996-02-05 |
1998-06-09 |
Hoechst Celanese Corporation |
Process for preparing pyrimidine derivatives
|
US5739330A
(en)
|
1996-02-05 |
1998-04-14 |
Hoechst Celanese Corporation |
Process for preparing quinazolones
|
WO1997028118A1
(en)
|
1996-02-05 |
1997-08-07 |
Hoechst Celanese Corporation |
Process for preparing anthranilic acids
|
PL328402A1
(en)
|
1996-02-12 |
1999-01-18 |
Rutgers |
Analoques of coralline as inhibitors of topoisomerase
|
JPH1029979A
(ja)
*
|
1996-04-12 |
1998-02-03 |
Ajinomoto Co Inc |
新規ピリジン誘導体
|
HUP9904567A3
(en)
|
1996-06-20 |
2001-10-29 |
Univ Texas |
Use of azo, thioalkyl, thiocarbonyl derivatives substituted by fused heterocycles and/or phenyl group for the preparation of pharmaceutical compositions stimulating bone growth
|
US5854264A
(en)
|
1996-07-24 |
1998-12-29 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
KR100213895B1
(ko)
|
1996-10-14 |
1999-08-02 |
박원훈 |
감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물
|
DE19651099A1
(de)
|
1996-12-09 |
1998-06-10 |
Consortium Elektrochem Ind |
Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung
|
IL119971A
(en)
|
1997-01-07 |
2003-02-12 |
Yissum Res Dev Co |
Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
WO1998051308A1
(en)
|
1997-05-13 |
1998-11-19 |
Octamer, Inc. |
METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS
|
US5908861A
(en)
|
1997-05-13 |
1999-06-01 |
Octamer, Inc. |
Methods for treating inflammation and inflammatory disease using pADPRT inhibitors
|
EP0988038B1
(en)
|
1997-06-02 |
2002-08-14 |
Janssen Pharmaceutica N.V. |
(imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
|
IL121165A0
(en)
|
1997-06-26 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical compositions containing carboxylic acids and derivatives thereof
|
AU8885498A
(en)
|
1997-08-29 |
1999-03-22 |
Takeda Chemical Industries Ltd. |
Triazine derivatives, their production and use
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
US6239114B1
(en)
|
1997-09-26 |
2001-05-29 |
Kgk Synergize |
Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
|
DE69839887D1
(de)
|
1997-10-02 |
2008-09-25 |
Eisai R&D Man Co Ltd |
Kondensierte pyridinderivate
|
CA2307891A1
(en)
|
1997-10-28 |
1999-05-06 |
Byung-Hwa Hyun |
Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
DE19756388A1
(de)
|
1997-12-18 |
1999-06-24 |
Hoechst Marion Roussel De Gmbh |
Substituierte 2-Aryl-4-amino-chinazoline
|
JP2002500039A
(ja)
|
1998-01-08 |
2002-01-08 |
アベンティス ファーマスーティカルズ プロダクツ インコーポレイテッド |
機能あるヒトリポタンパク質(a)を発現するトランスジェニックウサギ
|
US6414037B1
(en)
|
1998-01-09 |
2002-07-02 |
Pharmascience |
Pharmaceutical formulations of resveratrol and methods of use thereof
|
US6022901A
(en)
|
1998-05-13 |
2000-02-08 |
Pharmascience Inc. |
Administration of resveratrol to prevent or treat restenosis following coronary intervention
|
JP2002526488A
(ja)
|
1998-09-24 |
2002-08-20 |
三菱化学株式会社 |
ヒドロキシフラボン誘導体
|
CN1148188C
(zh)
|
1998-10-19 |
2004-05-05 |
卫材株式会社 |
镇痛剂
|
WO2000023073A1
(en)
|
1998-10-20 |
2000-04-27 |
Korea Institute Of Science And Technology |
Bioflavonoids as plasma high density lipoprotein level increasing agent
|
US6433187B1
(en)
|
1998-12-17 |
2002-08-13 |
Tularik Inc. |
Certain polycyclic compounds useful as tubulin-binding agents
|
US6291456B1
(en)
|
1998-12-30 |
2001-09-18 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
US6399633B1
(en)
|
1999-02-01 |
2002-06-04 |
Aventis Pharmaceuticals Inc. |
Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
|
PT1161438E
(pt)
|
1999-03-15 |
2004-09-30 |
Abbott Lab |
Macrolidos 6-o-substituidos com actividade antibacteriana
|
US6969720B2
(en)
|
1999-03-17 |
2005-11-29 |
Amr Technology, Inc. |
Biaryl substituted purine derivatives as potent antiproliferative agents
|
US6054435A
(en)
|
1999-03-19 |
2000-04-25 |
Abbott Laboratories |
6-O-substituted macrolides having antibacterial activity
|
SK15532001A3
(sk)
|
1999-04-28 |
2002-06-04 |
Aventis Pharma Deutschland Gmbh |
Deriváty kyselín s dvoma arylovými zvyškami ako ligandy receptorov PPAR a farmaceutické kompozície, ktoré ich obsahujú
|
US6835755B1
(en)
|
1999-06-24 |
2004-12-28 |
University Of Pretoria |
Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
|
DE19934799B4
(de)
|
1999-07-28 |
2008-01-24 |
Az Electronic Materials (Germany) Gmbh |
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
|
JP2001131151A
(ja)
|
1999-11-02 |
2001-05-15 |
Shionogi & Co Ltd |
オレフィン誘導体の新規用途
|
JP5278983B2
(ja)
|
1999-11-17 |
2013-09-04 |
塩野義製薬株式会社 |
アミド化合物の新規用途
|
JP4880847B2
(ja)
|
1999-12-06 |
2012-02-22 |
ウェリケム,バイオテック インコーポレーテッド |
ヒドロキシルスチルベンならびに新規スチルベン誘導体および類似体による抗炎症治療および乾癬治療ならびにプロテインキナーゼ阻害
|
FR2804679B1
(fr)
|
2000-02-07 |
2002-04-26 |
Clariant France Sa |
Nouveaux composes phenoliques derives des dialcoxyethanals, leur procede de preparation et leur application
|
JP2003522810A
(ja)
|
2000-02-17 |
2003-07-29 |
アップルトン ペーパーズ インコーポレイテッド |
アルコキシ又はアリルメトキシエタンの製造方法
|
WO2003018008A1
(fr)
|
2000-02-25 |
2003-03-06 |
Shionogi & Co., Ltd. |
Agent d'accélération de l'expression de apo ai
|
AU5261001A
(en)
|
2000-04-27 |
2001-11-12 |
Imperial Cancer Research Technology Ltd |
Condensed heteroaryl derivatives
|
AU6118001A
(en)
|
2000-05-03 |
2001-11-12 |
Tularik Inc |
Combination therapeutic compositions and methods of use
|
US6548694B2
(en)
|
2000-05-23 |
2003-04-15 |
Hoffman-La Roche Inc. |
N-(4-carbamimidoyl-phenyl)-glycine derivatives
|
JP2001335476A
(ja)
|
2000-05-29 |
2001-12-04 |
Shionogi & Co Ltd |
三環化合物の新規用途
|
WO2003024441A1
(fr)
|
2001-09-14 |
2003-03-27 |
Shionogi & Co., Ltd. |
Nouvelle utilisation de composes tricycliques
|
US6541522B2
(en)
|
2000-08-16 |
2003-04-01 |
Insmed Incorporated |
Methods of using compositions containing hypotriglyceridemically active stilbenoids
|
CA2356544C
(en)
|
2000-10-03 |
2006-04-04 |
Warner-Lambert Company |
Pyridotriazines and pyridopyridazines
|
CA2425097A1
(en)
|
2000-10-05 |
2002-04-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzamide compounds as apo b secretion inhibitors
|
JP2004532799A
(ja)
|
2000-10-11 |
2004-10-28 |
エスペリオン セラピューティクス,インコーポレイテッド |
コレステロール管理および関連用途のためのスルフィド化合物およびジスルフィド化合物ならびにそれらを含む組成物
|
US6673780B2
(en)
|
2000-10-11 |
2004-01-06 |
Esperion Therapeutics, Inc. |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
EP1348711B1
(en)
|
2000-11-30 |
2018-06-13 |
Canon Kabushiki Kaisha |
Luminescent element and display
|
KR20030059835A
(ko)
|
2000-12-07 |
2003-07-10 |
씨브이 쎄러퓨틱스, 인코포레이티드 |
관상동맥 질환 또는 동맥경화증에 대한 abca-1 상승화합물로서의 1,3,5-트리아진 및 피리미딘
|
KR100472694B1
(ko)
|
2000-12-30 |
2005-03-07 |
한국생명공학연구원 |
플라바논 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물
|
JP2002249483A
(ja)
|
2001-02-21 |
2002-09-06 |
Koei Chem Co Ltd |
アリール置換複素環式化合物の製造法
|
WO2002074307A1
(en)
|
2001-03-16 |
2002-09-26 |
Novogen Research Pty Ltd |
Treatment of restenosis
|
AU2002320025A1
(en)
|
2001-04-11 |
2002-11-11 |
Atherogenics, Inc. |
Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
|
JP2004535411A
(ja)
|
2001-05-25 |
2004-11-25 |
ブリストルーマイヤーズ スクイブ カンパニー |
マトリックスメタロプロテナーゼ及び/またはTNF−α転換酵素(TACE)の阻害剤としてのヒダントイン及び関連複素環化合物
|
WO2003007959A1
(en)
|
2001-07-16 |
2003-01-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinoxaline derivatives which have parp inhibitory action
|
US7173128B2
(en)
|
2001-08-13 |
2007-02-06 |
Ciba Specialty Chemicals Corporation |
Ultraviolet light absorbers
|
US7429593B2
(en)
|
2001-09-14 |
2008-09-30 |
Shionogi & Co., Ltd. |
Utilities of amide compounds
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
US6835469B2
(en)
|
2001-10-17 |
2004-12-28 |
The University Of Southern California |
Phosphorescent compounds and devices comprising the same
|
US7166368B2
(en)
|
2001-11-07 |
2007-01-23 |
E. I. Du Pont De Nemours And Company |
Electroluminescent platinum compounds and devices made with such compounds
|
US7250512B2
(en)
|
2001-11-07 |
2007-07-31 |
E. I. Du Pont De Nemours And Company |
Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
|
US6541045B1
(en)
|
2002-01-04 |
2003-04-01 |
Nutraceutical Corporation |
Herbal composition and method for combating inflammation
|
EP1477481B1
(en)
|
2002-01-28 |
2009-07-22 |
Ube Industries, Ltd. |
Process for producing quinazolin-4-one derivative
|
US20040127492A1
(en)
|
2002-02-19 |
2004-07-01 |
Pharmacia Corporation |
Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
TW200401770A
(en)
|
2002-06-18 |
2004-02-01 |
Sankyo Co |
Fused-ring pyrimidin-4(3H)-one derivatives, processes for the preparation and uses thereof
|
KR20040001144A
(ko)
|
2002-06-27 |
2004-01-07 |
김대경 |
신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법
|
US20050080021A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
|
US20040033480A1
(en)
|
2002-08-15 |
2004-02-19 |
Wong Norman C.W. |
Use of resveratrol to regulate expression of apolipoprotein A1
|
US20050080024A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives for the treatment of cardiovascular disorders
|
US20040087590A1
(en)
|
2002-08-23 |
2004-05-06 |
University Of Connecticut |
Novel biphenyl and biphenyl-like cannabinoids
|
EP1407774A1
(en)
|
2002-09-10 |
2004-04-14 |
LION Bioscience AG |
2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
|
EP1398032A1
(en)
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxo-quinazolines as LXR nuclear receptor binding compounds
|
AU2003284001A1
(en)
|
2002-10-07 |
2004-05-04 |
Bristol-Myers Squibb Company |
Triazolone and triazolethione derivatives
|
WO2004037176A2
(en)
|
2002-10-21 |
2004-05-06 |
Bristol-Myers Squibb Company |
Quinazolinones and derivatives thereof as factor xa inhibitors
|
WO2004039795A2
(en)
|
2002-10-29 |
2004-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds for the treatment of hyperlipidemia
|
EP1418164A1
(en)
|
2002-11-07 |
2004-05-12 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists
|
JP2006514624A
(ja)
|
2002-11-18 |
2006-05-11 |
エフ.ホフマン−ラ ロシュ アーゲー |
ジアジノピリミジン類
|
BR0315688A
(pt)
|
2002-11-22 |
2005-09-06 |
Japan Tobacco Inc |
Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
|
CN100418954C
(zh)
|
2002-12-13 |
2008-09-17 |
弗·哈夫曼-拉罗切有限公司 |
3h-喹唑啉-4-酮衍生物
|
ITRM20020629A1
(it)
|
2002-12-19 |
2004-06-20 |
Sigma Tau Ind Farmaceuti |
Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
|
DE60335911D1
(de)
|
2002-12-20 |
2011-03-10 |
Daiichi Sankyo Co Ltd |
Isochinolinonderivate und deren verwendung als medikamente
|
JP2004203751A
(ja)
|
2002-12-24 |
2004-07-22 |
Pfizer Inc |
置換6,6−ヘテロ二環式誘導体
|
JP4500689B2
(ja)
|
2002-12-26 |
2010-07-14 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
選択的エストロゲン受容体モジュレーター
|
WO2004065392A1
(en)
|
2003-01-24 |
2004-08-05 |
Smithkline Beecham Corporation |
Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
|
WO2004072042A2
(en)
|
2003-02-12 |
2004-08-26 |
Carex S.A. |
Quinoline derivative and their use for modulation of lxr activity
|
EP1615906A1
(en)
|
2003-04-03 |
2006-01-18 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
JP4895806B2
(ja)
|
2003-04-09 |
2012-03-14 |
エクセリクシス, インク. |
Tie−2モジュレータと使用方法
|
JP2004307440A
(ja)
|
2003-04-10 |
2004-11-04 |
Kyorin Pharmaceut Co Ltd |
2−アミノ‐1,3‐プロパンジオール誘導体とその付加塩
|
ES2386161T3
(es)
|
2003-04-16 |
2012-08-10 |
Bristol-Myers Squibb Company |
Proceso para separar una mezcla de enantiómeros de éster alquílico usando una enzima
|
WO2004112710A2
(en)
|
2003-06-17 |
2004-12-29 |
Millennium Pharmaceuticals, Inc. |
COMPOSITIONS AND METHODS FOR INHIBITING TGF-ß
|
US20060270849A1
(en)
|
2003-06-18 |
2006-11-30 |
Shigeyoshi Nishino |
Process for producing pyrimidin-4-one compound
|
US20050043300A1
(en)
|
2003-08-14 |
2005-02-24 |
Pfizer Inc. |
Piperazine derivatives
|
JP2007509035A
(ja)
|
2003-10-10 |
2007-04-12 |
レスバーロジックス コーポレイション |
Egr−1エンハンサー要素に関連する疾患の処置
|
JP2007517071A
(ja)
|
2003-12-19 |
2007-06-28 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
US20080188527A1
(en)
|
2003-12-23 |
2008-08-07 |
Cashman John R |
Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer
|
TW200536830A
(en)
|
2004-02-06 |
2005-11-16 |
Chugai Pharmaceutical Co Ltd |
1-(2H)-isoquinolone derivative
|
AU2005247808B2
(en)
|
2004-05-31 |
2011-02-10 |
Msd K.K. |
Quinazoline derivative
|
WO2006012577A2
(en)
*
|
2004-07-22 |
2006-02-02 |
Bayer Pharmaceuticals Corporation |
Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake
|
US20070218155A1
(en)
|
2004-08-20 |
2007-09-20 |
Kuhrts Eric H |
Methods and compositions for treating dyslipidaemia
|
WO2006045096A2
(en)
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
|
EP1844023A1
(en)
|
2004-12-31 |
2007-10-17 |
Sk Chemicals Co., Ltd. |
Quinazoline derivatives for the treatment and prevention of diabetes and obesity
|
CR9465A
(es)
|
2005-03-25 |
2008-06-19 |
Surface Logix Inc |
Compuestos mejorados farmacocineticamente
|
AU2006275514B2
(en)
|
2005-07-29 |
2012-04-05 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
CA2634491A1
(en)
|
2005-12-21 |
2007-06-28 |
Painceptor Pharma Corporation |
Compositions and methods for modulating gated ion channels
|
US8053440B2
(en)
*
|
2007-02-01 |
2011-11-08 |
Resverlogix Corporation |
Compounds for the prevention and treatment of cardiovascular diseases
|
EP2005941A3
(de)
|
2007-06-01 |
2009-04-01 |
Henkel AG & Co. KGaA |
Zellverjüngende Zusammensetzungen
|
EP2382194B1
(en)
|
2009-01-08 |
2014-03-12 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|